Rocket Pharmaceuticals completes $180 million priority review voucher sale

Go back to Rocket Pharmaceuticals completes $180 million priority review voucher sale
(NASDAQ: RCKT) Delayed: 3.73 -0.13 (3.37%)
Previous Close $3.86    52 Week High
Open $3.78    52 Week Low
Day High $3.78    P/E N/A 
Day Low $3.68    EPS
Volume 549,356